logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Lei Xiao

LinkedIn

This inventor holds 13 USPTO granted patents and 28 published patent applications and 1 EPO patent. Top assignees: Innovative Cellular Therapeutics Holdings, Ltd., Innovative Cellular Therapeutics, Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Xiao. Retrieved from https://idiyas.com/inventor/lei-xiao-papzw49s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 61.5

 

Average Co-Inventor Count = 5.4

ph-index = 1


Company Filing History:

goldMedal13 out of 31 
 
Innovative Cellular Therapeutics Holdings, Ltd.
 patents
silverMedal11 out of 15 
 
Innovative Cellular Therapeutics, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2024-2026

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12760117 - Nanobody Target MSLN and Uses in Chimeric Antigen Receptor Cell Therapy (2026-10-13),
2. 12709737 - Enhanced Chimeric Antigen Receptor Cells in Hypoxic Tumor Microenvironment (2026-08-18),
3. 12708672 - Vaccine and Uses thereof in Cell Therapy (2026-08-18),
4. 12702708 - Presenting cell and use thereof in cell therapy (2026-08-11),
5. 12685774 - CELL/GENE THERAPIES TARGETING MAGE-A4 PEPTIDE (2026-07-21),
6. 12297267 - Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor (2025-05-13),
7. 12240915 - Chimeric antigen receptor cells for treating solid tumor (2025-03-04),
8. 12150960 - Modified cell expansion and uses thereof (2024-11-26),
9. 12076343 - Engineered safety in cell therapy (2024-09-03),
10. 12043654 - Anti-GCC antibody and CAR thereof for treating digestive system cancer (2024-07-23),
11. 11970548 - Nanobody target GCC and uses in chimeric antigen receptor cell therapy (2024-04-30),
12. 11944645 - Modified cell and use thereof in gene and cell therapy (2024-04-02),
13. 11932700 - Use of chimeric antigen receptor modified cells to treat cancer (2024-03-19),

Title: Biography of Inventor Lei Xiao

Introduction

Lei Xiao is an accomplished inventor based in Rockville, MD (US), known for his significant contributions to the field of biotechnology. He holds a total of 8 patents, showcasing his innovative approach to medical treatments.

Latest Patents

Among his latest patents is the development of a humanized anti-CD19 antibody and its application in treating diseases. This invention relates to humanized CD19 antibodies that can be administered to subjects with CD19 positive tumors, providing a therapeutically effective treatment option. Another notable patent involves chimeric antigen receptor (CAR) cells designed for treating solid tumors, utilizing CAR T therapy. These compositions include CARs that bind to specific proteins or receptors, enhancing the effectiveness of cancer treatments.

Career Highlights

Throughout his career, Lei Xiao has worked with various organizations, including Innovative Cellular Therapeutics Holdings, Ltd. and Innovative Cellular Therapeutics, Inc. His work has significantly advanced the understanding and treatment of cancer through innovative therapeutic approaches.

Collaborations

Lei has collaborated with esteemed colleagues such as Zhiyuan Cao and Chengfei Pu, contributing to the development of groundbreaking therapies in the field of cellular therapeutics.

Conclusion

With a strong portfolio of patents and a commitment to advancing medical science, Lei Xiao continues to be a prominent figure in the biotechnology industry. His innovative work is paving the way for new treatment

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…